Summary
Task 113 Implementation of the Think Tank M6M24 GSK NICE ZIN UMCU SARD Takeda Lilly AZ UCB Bayer Amgen UMCG LASER Delivery date M6 12 18 24The appointed members of the Think Tank will convene periodically virtual andor in reallife to enable scientific exchange to prioritize RWE barriers andor opportunities and to discuss results from the Task Forces The outcomes of the Think Tank can lead to vision documents including priority areas for future research and policy recommendations In the event that a new Task Force is recommended by the Think Tank the EPMT will approve the initiation of activities and make the final decision The Think Tank members will help define the scope of the Task Force help identify Task Force Leaders support the identification of Task Forces contributors WP3 will work with the Task Force Leaders to define the timelines for delivery and allocate budget The Think Tank will also review outputs from ongoing Task Forces and work with Task Forces eg through consultations to implement their dissemination and stakeholder engagement plan Members of the Think Tank will act as global ambassadors for the outputs of the Task Forces The outcomes of the meetings will be recorded D12D13D14D15In addition to Task Forces the Think Tank will also identify topics to be discussed in a broader scientific forum It is envisaged that two large scientific meetings will be conducted throughout the duration of the current project The model of these meetings will be based on the successful closing event of IMI GetReal in Brussels in November 2016 and the stakeholder round table in June 2016 in London Project Management event management and stakeholder engagement activities conducted by the Think Tank and Task Force Leaders will be supported by WP3
More information & hyperlinks
